Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

657
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
657
Patient-centered Care01:13

Patient-centered Care

2.5K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.5K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

33
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
33
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Methods for Assessing Therapeutic Innovation of Drugs: Changes at the Italian Medicine Agency.

Therapeutic innovation & regulatory science·2026
Same journal

FDA Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites: Testing Presence, Prominence, and Wording.

Therapeutic innovation & regulatory science·2026
Same journal

A Regulatory-Ready Bayesian Evidence Framework across Clinical Development and Pharmacovigilance: Practical Expectations from FDA, EMA, and ICH Guidance.

Therapeutic innovation & regulatory science·2026
Same journal

How Digital Health Technologies have been Used to Support Regulatory Drug Approval.

Therapeutic innovation & regulatory science·2026
Same journal

Application of the Child-Pugh Classification in Japanese Drug Labeling: A Cross-Sectional Analysis of Contraindications, Dose Recommendations, and Pharmacokinetic Rationale.

Therapeutic innovation & regulatory science·2026
Same journal

Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece.

Therapeutic innovation & regulatory science·2026

Related Experiment Video

Updated: Oct 18, 2025

Spotlighting Customers' Visual Attention at the Stock, Shelf and Store Levels with the 3S Model
06:30

Spotlighting Customers' Visual Attention at the Stock, Shelf and Store Levels with the 3S Model

Published on: May 24, 2019

5.4K

Exploring How and Why to Develop Patient-Centered Packaging: A Multiple-Case Study with Pharmaceutical Companies.

Giana Carli Lorenzini1, Annika Olsson2

  • 1Packaging Logistics, Department of Design Sciences, Lund University, Box 118, SE 221 00, Lund, Sweden. giana.carli_lorenzini@plog.lth.se.

Therapeutic Innovation & Regulatory Science
|September 28, 2021
PubMed
Summary

Patient-centered packaging development is uncommon but offers significant benefits. Pharmaceutical companies should integrate patient needs early in packaging design to overcome challenges and create meaningful solutions.

Keywords:
Multiple-case studyPackaging developmentPatient-centered packagingPharmaceutical industryWorkshops

More Related Videos

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.9K
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.2K

Related Experiment Videos

Last Updated: Oct 18, 2025

Spotlighting Customers' Visual Attention at the Stock, Shelf and Store Levels with the 3S Model
06:30

Spotlighting Customers' Visual Attention at the Stock, Shelf and Store Levels with the 3S Model

Published on: May 24, 2019

5.4K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.9K
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

2.2K

Area of Science:

  • Pharmaceutical packaging
  • Patient-centric design
  • Healthcare innovation

Background:

  • Growing demand for patient centricity in drug development.
  • Lack of empirical evidence on patient-centric medication packaging.
  • Need for pharmaceutical companies to adopt patient-focused approaches.

Purpose of the Study:

  • Explore patient centricity in pharmaceutical packaging.
  • Identify challenges in developing patient-centered packaging.
  • Document lessons learned from patient-centered packaging initiatives.

Main Methods:

  • Multiple-case study research approach.
  • Analysis of five cases of patient-centered packaging development.
  • Involvement of mid- and large-sized pharmaceutical companies.

Main Results:

  • Patient-centered packaging enhances intuitive medication use.
  • Development presents challenges but offers opportunities for patient solutions.
  • Key to success: a strong business case, early patient input, and stakeholder alignment.

Conclusions:

  • Patient-centered packaging is currently the exception, not the norm.
  • Conventional approaches prioritize drug protection over patient needs.
  • Case studies can inspire wider adoption and promote dialogue on patient centricity.